Pulmonary Health http://pulmonary-health.com Valuable Information On Pulmonary Health For You To Battle COPD, Emphyzema and Other Pulmonary Diseases Mon, 21 May 2012 19:38:11 +0000 http://backend.userland.com/rss092 en Director’s Comments: NIH MedlinePlus Magazine Spring 2012 Listen

Listen to the NLM Director's Comments on "NIH MedlinePlus Magazine Spring 2012". The transcript is also available.

The new edition of NIH MedlinePlus magazine encourages physical fitness, and provides a better understanding of multiple sclerosis, information about your thyroid gland, and control of seasonal allergies.

]]> http://pulmonary-health.com/directors-comments-nih-medlineplus-magazine-spring-2012/ Pulmonary Rehabilitation Improves Survival in COPD – Newswise (press release)
Pulmonary Rehabilitation Improves Survival in COPD
Newswise (press release)
Newswise — ATS 2012, SAN FRANCISCO – Pulmonary rehabilitation and improvement in exercise capacity significantly improves survival in patients with chronic obstructive pulmonary disease (COPD), according to a new study from the UK.
Comorbidities are common in patients with COPDEurekAlert (press release)

all 7 news articles »
]]> http://pulmonary-health.com/pulmonary-rehabilitation-improves-survival-in-copd-newswise-press-release/ Minister and charity CEO visit pioneering COPD work at Chelsea and Westminster … – Kensington and Chelsea Today
Minister and charity CEO visit pioneering COPD work at Chelsea and Westminster ...
Kensington and Chelsea Today
The visit was to see first-hand the pioneering approach being taken by the hospital to tackling the widespread lung condition Chronic Obstructive Pulmonary Disease (COPD). The approach has been proven to significantly reduce the readmission rates after ...

]]> http://pulmonary-health.com/minister-and-charity-ceo-visit-pioneering-copd-work-at-chelsea-and-westminster-kensington-and-chelsea-today/ Results of Phase II Study of Boehringer Ingelheim’s Investigational … – MarketWatch (press release)
Results of Phase II Study of Boehringer Ingelheim's Investigational ...
MarketWatch (press release)
This data completes the olodaterol monotherapy Phase II clinical trial program in patients with COPD. "In this Phase II study, olodaterol administered once daily provided significant bronchodilation over a complete 24-hour period," said Professor Guy ...

and more »
]]> http://pulmonary-health.com/results-of-phase-ii-study-of-boehringer-ingelheims-investigational-marketwatch-press-release/ Pulmatrix Announces Presentation of Clinical Data Demonstrating iCALM Inhaled … – MarketWatch (press release)
Pulmatrix Announces Presentation of Clinical Data Demonstrating iCALM Inhaled ...
MarketWatch (press release)
"We are strongly committed to advancing a pipeline of iCALM therapies to treat chronic respiratory diseases, including COPD, asthma and cystic fibrosis." "iCALM's ability to limit allergen-induced eosinophilic airway inflammation in this trial is ...

and more »
]]> http://pulmonary-health.com/pulmatrix-announces-presentation-of-clinical-data-demonstrating-icalm-inhaled-marketwatch-press-release/ COPD Can Put a Damper on Sex Life – MSN Health & Fitness
COPD Can Put a Damper on Sex Life
MSN Health & Fitness
MONDAY, May 21 (HealthDay News) -- Shortness of breath during sexual activity is common for patients with chronic obstructive pulmonary disease (COPD), a new, small study finds. This breathlessness, also known as dyspnea, can inhibit healthy sex lives ...
Troublesome dyspnea during sexual activity is common in COPD patientsMedical Xpress
Dyspnea During Sexual Activity is Common in COPD PatientsNewswise (press release)

all 9 news articles »
]]> http://pulmonary-health.com/copd-can-put-a-damper-on-sex-life-msn-health-fitness/ Biopharma raising $500K eyes competitive asthma/COPD drug market – MedCity News
Biopharma raising $500K eyes competitive asthma/COPD drug market
MedCity News
Aside from respiratory diseases like asthma and COPD, the company is also devoting research efforts to using its technology in the treatment of inflammation and cardiovascular diseases like hypertension, according to its website.

]]> http://pulmonary-health.com/biopharma-raising-500k-eyes-competitive-asthmacopd-drug-market-medcity-news/ Novartis Progresses with NVA237 – Zacks.com
Novartis Progresses with NVA237
Zacks.com
The candidate is being studied for the treatment of chronic obstructive pulmonary disease (COPD). The study showed rapid improvement in lung function and symptom relief over one year in COPD patients. Data from the phase III GLOW 2 study showed that ...
Novartis reports positive data from COPD drug trialZenopa
Novartis Sees Positive Phase III Data for COPD CandidateFDA news (subscription)
Novartis NVA237 Phase III data showed rapid, sustained improvement in lung ...PharmiWeb.com (press release)

all 6 news articles »
]]> http://pulmonary-health.com/novartis-progresses-with-nva237-zacks-com/ Pearl Therapeutics Receives TiE50 Award from Global Entrepreneurship Network – MarketWatch (press release)
Pearl Therapeutics Receives TiE50 Award from Global Entrepreneurship Network
MarketWatch (press release)
These elements have allowed us to progress a family of bronchodilator products for COPD patients while conforming to the strictest product development standards and maintaining a capital efficient business plan. We believe that these foundations will ...

and more »
]]> http://pulmonary-health.com/pearl-therapeutics-receives-tie50-award-from-global-entrepreneurship-network-marketwatch-press-release/ Emphysema: MedlinePlus – National Library of Medicine – National … http://pulmonary-health.com/emphysema-medlineplus-national-library-of-medicine-national/